Nasdaq3d
J&J Seeks FDA Nod for Non-Muscle Invasive Bladder Cancer Drug
Johnson & Johnson JNJ has initiated a rolling submission with the FDA seeking approval for TAR-200, its investigational drug-device combination to treat certain patients with non-muscle invasive ...
Nasdaq2d
FDA Okays LLY's Omvoh for Second Inflammatory Bowel Disease Condition
Eli Lilly and Company LLY announced that the FDA has granted approval to its drug ... list of today’s Zacks #1 Rank (Strong Buy) stocks here. It's only 1/9,000th the size of NVIDIA which ...
Nasdaq6d
22nd Century Group Supports FDA's Proposed Reduced Nicotine Content Standard Following OMB Review Completion
The FDA spokesperson indicated that the policy could ... 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should ...
Nasdaq3d
FDA Approves Lilly's Omvoh For Crohn's Disease Treatment
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New York ...
Nasdaq5d
Firefly Neuroscience Advances Brain Age Assessment Research with FDA-Cleared BNAâ„¢ Technology
Firefly (NASDAQ: AIFF) is an Artificial Intelligence ... for patients with neurological and mental disorders. Firefly’s FDA-510(k) cleared Brain Network Analytics (BNA™) technology ...
Nasdaq4d
FDA Reduced Nicotine Proposal Could Benefit 13 Mln Smokers, Highlights 22nd Century's VLN Cigarettes
VLN cigarettes are the first and only combustible tobacco products authorized by the FDA under its Modified Risk ... do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s ...
Nasdaq6d
SeaStar Medical Receives FDA Approval for SCD-ADULT Study Funded by $3.6 Million NIH Grant
FDA approves SeaStar Medical's SCD-ADULT study ... check out Quiver Quantitative's insider trading dashboard. (Nasdaq: ICU), a commercial-stage medical device company developing proprietary ...
Nasdaq3d
Incyte And Syndax : FDA Approves Niktimvo 9 Mg And 22 Mg Vial Sizes
Niktimvo is the first and only FDA-approved prescription treatment for ... of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan ...
Nasdaq5d
Top 5 Small-cap Medical Device Stocks (Updated January 2025)
Below, the Investing News Network has compiled a list of the top NASDAQ medical device companies ... it is marketed in combination with melphalan as the FDA-approved Hepzato Kit, which is ...
Nasdaq4d
22nd Century Group's VLN Reduced Nicotine Cigarettes Gain FDA Authorization Amid New Smoking Reduction Policies
22nd Century Group, Inc. has been highlighted in a Washington Post article discussing new FDA policies aimed at reducing the health risks associated with smoking, particularly through the ...
Nasdaq5d
FDA Accepts Eisai And Biogen's BLA For Subcutaneous LEQEMBI For Early Alzheimer's Disease
The US FDA accepted Eisai's Supplemental Biologics ... and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New ...
Nasdaq6d
NeurAxis, Inc. CEO Brian Carrico Shares 2024 Achievements and Vision for 2025 in Shareholder Letter
Notable milestones in 2024 included the expansion of IB-Stim’s patient range, increased insurance coverage, and the receipt of FDA clearances for both IB-Stim and RED, alongside the approval of ...